DR LAL PATHLABS Financial Statement Analysis
|
||
|
The Revenues of DR LAL PATHLABS have increased by 10.54% YoY .
The Earnings Per Share (EPS) of DR LAL PATHLABS has decreased by -48.30 % YoY. |
||
DR LAL PATHLABS Last 5 Annual Financial Results
[BOM: 539524|NSE : LALPATHLAB]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹2,461 Cr | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr |
| Expenses | ₹1,766 Cr | ₹1,617 Cr | ₹1,527 Cr | ₹1,527 Cr | ₹1,145 Cr |
| Operating Profit (Excl OI) | ₹696 Cr | ₹609 Cr | ₹490 Cr | ₹561 Cr | ₹436 Cr |
| Other Income | ₹93 Cr | ₹69 Cr | ₹42 Cr | ₹53 Cr | ₹51 Cr |
| Interest | ₹22 Cr | ₹29 Cr | ₹38 Cr | ₹30 Cr | ₹16 Cr |
| Depreciation | ₹142 Cr | ₹144 Cr | ₹150 Cr | ₹108 Cr | ₹77 Cr |
| Profit Before Tax | ₹625 Cr | ₹505 Cr | ₹344 Cr | ₹475 Cr | ₹394 Cr |
| Profit After Tax | ₹492 Cr | ₹362 Cr | ₹241 Cr | ₹350 Cr | ₹296 Cr |
| Consolidated Net Profit | ₹487 Cr | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr |
| Earnings Per Share (Rs) | ₹30.13 | ₹58.28 | ₹42.85 | ₹28.65 | ₹41.37 |
| PAT Margin (%) | 18.45 | 20.00 | 16.27 | 11.95 | 16.78 |
| ROE(%) | 22.37 | 25.15 | 21.27 | 15.80 | 26.45 |
| ROCE(%) | 29.56 | 31.53 | 27.89 | 20.34 | 32.67 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.05 | 0.15 | 0.24 |
Key Financials |
||
| Market Cap | : | ₹ 32,299.9 Cr |
| Revenue (TTM) | : | ₹ 2,890.8 Cr |
| Net Profit(TTM) | : | ₹ 546.3 Cr |
| EPS (TTM) | : | ₹ 32.6 |
| P/E (TTM) | : | 59.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DR LAL PATHLABS | 1% | 16.7% | 21.8% |
| APOLLO HOSPITALS ENTERPRISE | -1.6% | 0.7% | 19.7% |
| MAX HEALTHCARE INSTITUTE | -2.1% | -0.9% | -14.6% |
| FORTIS HEALTHCARE | -1% | -0.9% | 9.7% |
| ASTER DM HEALTHCARE | 2.7% | 8.3% | 42% |
| NARAYANA HRUDAYALAYA | -7.1% | -4.7% | -1.8% |
| GLOBAL HEALTH | 2.3% | 10.3% | 8% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.4% | 0.2% | 7.5% |
| DR AGARWALS HEALTH CARE | 11% | 11.5% | 14.9% |
DR LAL PATHLABS Revenues
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 10.54 % |
| 5 Yr CAGR | 11.70 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,461 Cr | 10.54 | |
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | - | |
DR LAL PATHLABS Operating Profit
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 14.17 % |
| 5 Yr CAGR | 12.37 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹696 Cr | 14.17 | |
| Mar2025 | ₹609 Cr | 24.38 | |
| Mar2024 | ₹490 Cr | -12.64 | |
| Mar2023 | ₹561 Cr | 28.52 | |
| Mar2022 | ₹436 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 3.29 % |
| 5 Yr CAGR | 0.60 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 28.26% | 3.29 | |
| Mar2025 | 27.36% | 12.64 | |
| Mar2024 | 24.29% | -9.57 | |
| Mar2023 | 26.86% | -2.65 | |
| Mar2022 | 27.59% | - | |
DR LAL PATHLABS Profit After Tax
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | 36.17 % |
| 5 Yr CAGR | 13.69 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹487 Cr | 36.17 | |
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -7.75 % |
| 5 Yr CAGR | 2.40 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 18.45 % | -7.75 | |
| Mar2025 | 20 % | 22.93 | |
| Mar2024 | 16.27 % | 36.15 | |
| Mar2023 | 11.95 % | -28.78 | |
| Mar2022 | 16.78 % | - | |
DR LAL PATHLABS Earnings Per Share (EPS)
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | -48.30 % |
| 5 Yr CAGR | -7.62 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹30 | -48.30 | |
| Mar2025 | ₹58 | 36.01 | |
| Mar2024 | ₹43 | 49.56 | |
| Mar2023 | ₹29 | -30.75 | |
| Mar2022 | ₹41 | - | |
DR LAL PATHLABS Return on Capital Employed (ROCE)
[BOM: 539524|NSE : LALPATHLAB]
| Y-o-Y | -6.25 % |
| 5 Yr CAGR | -2.47 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 29.56% | -6.25 | |
| Mar2025 | 31.53% | 13.05 | |
| Mar2024 | 27.89% | 37.12 | |
| Mar2023 | 20.34% | -37.74 | |
| Mar2022 | 32.67% | - | |
DR LAL PATHLABS Share Price vs Sensex
| Current Share Price | : | ₹1,927.2 |
| Current MarketCap | : | ₹ 32,299.9 Cr |
| Updated EOD on | : | Aug 06,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 1% |
16.7% |
21.8% |
| SENSEX | 1.3% |
1% |
-2.9% |
DR LAL PATHLABS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE SMALLCAP SELECT INDEX | 3.3% | 4.3% | 12.7% |
| BSE 250 SMALLCAP INDEX | 3% | 2.1% | 4.3% |
| BSE 400 MIDSMALLCAP INDEX | 2% | 2.2% | 6.6% |
| BSE 1000 | 1.9% | 1.9% | 3.3% |
| BSE 500 | 1.7% | 1.7% | 2.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 50 | 3.7% | 4.3% | 12.6% |
| NIFTY SMALLCAP 500 | 3.4% | 2.6% | NA |
| NIFTY SMALLCAP250 MOMENTUM QUALITY 100 INDEX | 3.4% | 2.5% | 4.4% |
| NIFTY SMALLCAP 100 | 3.2% | 3.5% | 8.9% |
| NIFTY TOTAL MARKET MOMENTUM QUALITY 50 | 3% | 1.8% | NA |
You may also like the below Video Courses
FAQ about DR LAL PATHLABS Financials
How the annual revenues of DR LAL PATHLABS have changed ?
The Revenues of DR LAL PATHLABS have increased by 10.54% YoY .
How the Earnings per Share (EPS) of DR LAL PATHLABS have changed?
The Earnings Per Share (EPS) of DR LAL PATHLABS has decreased by -48.30 % YoY .
Check out Intrinsic Value of Peers of DR LAL PATHLABS
Compare Stock Analytics of Peers of DR LAL PATHLABS
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
APOLLO HOSPITALS ENTERPRISE LTD vs MAX HEALTHCARE INSTITUTE LTD vs FORTIS HEALTHCARE LTD
ASTER DM HEALTHCARE LTD vs NARAYANA HRUDAYALAYA LTD vs
